Skip to content

Absorption Profiles of Three Polyphenol Preparations With and Without Pollen Shell Covering

Investigation Into Polyphenol Absorption Profiles

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02116816
Enrollment
40
Registered
2014-04-17
Start date
2014-04-30
Completion date
2015-05-31
Last updated
2019-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polyphenols Absorption Profile

Brief summary

This study consists of two parts. The first part of the study looked at the absorption of three different polyphenol preparations into the blood, the variability of their absorption and whether their absorption could be enhanced by mixing with pollen shells. For this purpose 12 healthy volunteers were recruited. All participants received all the 3 supplements with and without mixing with pollen shells so they had a total of 3 tests. For each test six blood samples were taken over an 8 hour period. Urine samples were also collected. Oligopin was selected from the first study. The second part of study aims to look at the effects of Oligopin on endothelial function by assessing vascular tone and function in healthy volunteers using a non-invasive, direct measurement of vasodilatory capacity (EndoPAT). Nitrate and nitrite measurements, as well as blood pressure measurements, will also be recorded to provide a clear clinical assessment of the effects of this preparation (if any) upon vascular function. The effects of Oligopin will be compared to a placebo (methylcellulose-filled capsules) to allow a robust assessment of any clinical effects. A total of 24 healthy volunteers will be recruited for this study.

Detailed description

This study consists of two parts. The first part of the study looked at the absorption of three different polyphenol preparations into the blood, the variability of their absorption and whether their absorption could be enhanced by mixing with pollen shells (pollen shells have been shown to enhance lipid molecule absorption). For this purpose 12 healthy volunteers were recruited. All participants received all the 3 supplements with and without mixing with pollen shells so they had a total of 3 tests. For each test six blood samples were taken over an 8 hour period. Urine samples were also collected. Oligopin was selected from the first study. The second part of study aims to look at the effects of Oligopin on endothelial function by assessing vascular tone and function in healthy volunteers using a non-invasive, direct measurement of vasodilatory capacity (EndoPAT). Nitrate and nitrite measurements, as well as blood pressure measurements, will also be recorded to provide a clear clinical assessment of the effects of this preparation (if any) upon vascular function. The effects of Oligopin will be compared to a placebo (methylcellulose-filled capsules) to allow a robust assessment of any clinical effects. A total of 24 healthy volunteers will be recruited for this study.

Interventions

DIETARY_SUPPLEMENTPolyphenol

Polyphenol

Sponsors

Hull University Teaching Hospitals NHS Trust
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. Male or Female subjects between the age of 18-65 who can speak and understand English 2. No concomitant medication including herbal medicines and food supplements 3. No concomitant disease processes 4. Body Mass Index 21- 29kg/m2 5. Systolic blood pressure ≤150 mm Hg and diastolic pressure \<90 mm Hg 6. Subjects who have given informed consent

Exclusion criteria

1. Patients not wishing to allow disclosure to their GPs. 2. Concomitant medication including herbal medicines and food supplements 3. Concomitant disease processes 4. History of drug/alcohol abuse or Alcohol intake within 24 hours of dosing visit (visits 2-4) 5. Body Mass Index \<21 and \> 29kg/m2 6. Systolic blood pressure \>150 mm Hg and or a diastolic pressure\>90 mm Hg 7. Unable to tolerate polyphenol products or adhere to low polyphenol diet 8. Vegetarian 9. Subjects not willing or able to fast until 12 noon (a total of 14 hours). 10. Pregnant females or planning to conceive in the next 3 months. 11. Participation in any other study currently or in the last three months.

Design outcomes

Primary

MeasureTime frameDescription
Area Under the Absorption Curve for each polyphenol preparation8 hoursBlood samples will be withdrawn 6 times over an 8 hour period: baseline, then 30 minutes, 1 hour, 2 hours, 4 hours and 8 hours after ingestion of each polyphenol supplement (total 3 supplements)

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026